NRAS and cholangiocarcinoma: In the current study, we mainly used the SB-HDTVI-based Akt-YAP1 and Akt-NRAS HC-derived cHCC-CCA models to investigate the roles of Sox9 in the liver cancer setting, including cHCC-CCA.